Early Promise for New Agent in Congenital Hyperinsulinism in Kids
Exendin-(9-39) may offer some children born with this rare disease, which results in excessively low blood glucose, an alternative to near-total pancreatectomy.
Source: medscape.com
Poxel Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Poxel Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Poxel Pharma Today - Breaking & Trending Today